Roberto Veronese

Roberto Veronese is an accomplished entrepreneur and investor in the biotechnology sector, currently serving as the Founder and CEO of Accelera BIO since March 2020, a platform designed to accelerate growth for biotech ventures. Veronese also holds advisory roles with ArteraAI, recognized for its AI-based cancer test, and has provided fractional leadership for GRAIL, known for the multi-cancer early detection test, Galleri. With extensive experience in product development and design, previous positions include Vice President at Helix, where Veronese led the transition to population genomics, and Director at frog, facilitating product strategies across the biotech and healthcare industries. Additional experience consists of managing user experience and service innovation at Value Partners and founding Nexterior, a product design firm. Veronese's educational background includes executive education in fields such as telehealth strategy and AI product development from prestigious institutions like Stanford University and MIT.